Aug. 12 at 8:43 PM
$CTXR $CTOR ER summary
• Lymphir launch expected Q4 2025
• "After giving effect to the July 17, 2025 financing by Citius Oncology, we expect that we will have sufficient funds to continue our operations through September 2025. "
• ATM use: During the three months ended June 30, 2025, CTXR sold 2,185,249 shares for gross proceeds of
$3,471,866.
CTXR had
$6.1m in cash and CTOR had
$112 in cash as of June 30. This does not include the net proceeds of
$7.4m that CTOR received from the July offering.
CTXR confirmed that after June 30, 2.45m of the pre-funded warrants from the June offering were exercised.
Full summary, with links to the ERs and 10-Qs --> https://www.reddit.com/r/CTXR/comments/1mokb22/ctxr_and_ctor_release_financial_results_and/
